Bristol-Myers and Pfizer will make an undisclosed payment to Portola for testing the reverse effect of PRT4445 on anticoagulant Factor Xa inhibitor drugs including Eliquis and will provide
The 80,000ft² expansion will facilitate insulin cartridge manufacturing for people with diabetes and will help meet the diabetes demand in the country. Lilly chairman, president and chief executive
The dose-ranging study will enroll healthy subjects and the clinical data are anticipated by the end of 2012. Omeros chairman and chief executive officer Gregory Demopulos said OMS824
The agreement reflects SAFC’s pre-formulation services contract into the South Korean pharmaceutical market. As part of the agreement, CrystalGenomics will use UK-based SAFC’s Pharmorphix Pre-formulation Technology services to
Victorian Government Technology Minister Gordon Rich-Phillips said the Government’s Enabling Technologies Skills Strategy – Biotechnology: 2012-15 will further develop the commercial, business and technical skills of Victoria’s biotechnology
The production facility will be co-located with the pharmaceutical production site based in Tuas, Singapore. Novartis CEO Joseph Jimenez said, "We have chosen Singapore as strategic supply point
The data reveales the relationship (p=0.003) between EVP-6124 plasma concentrations and the probability of cognitive improvement measured by the Alzheimer’s Disease Assessment Scale-Cognitive subscale-13. EnVivo Pharmaceuticals president and
Nefecon, an enteric formulation of a locally-acting and potent corticosteroid, inhibits the gastrointestinal immune system and down regulates the IgA nephropathy disease process. Commercial terms of the agreement
Adcetris is indicated for use in adult patients with relapsed or refractory CD30 positive Hodgkin lymphoma (HL) or relapsed or refractory systemic anaplastic large cell lymphoma (sALCL). The
The company anticipates launching the generic drug in or prior to the first quarter of 2013. Sihuan chairman and CEO Dr. Che Fengsheng said based on the hospital
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.